METHOD
Complications were classified as follows: local implant infection responsive to oral antibiotics, persistent infection (more than 7 days), and partial exposure with or without infection. The severity of infection was an important factor in deciding whether or not to attempt to salvage. Oral antibiotics (amoxicillin + clavulanate and trimetoprim + sulfametoxazol/clindamycin) were given in case of initial infection for 7 days. In case of persistent infection or in case of partial implant exposure, intravenous antibiotics (piperacillin + tazobactam/ampicillin + sulbactam and vancomycin/teicoplanin) were administered for at least 10 days and immediate surgical operation was performed. Operative steps included wound cultures collection; implant removal; pulse lavage; capsulectomy; and device exchange for the same type of implant in augmentation mammoplasty or for a smaller and less projected prosthesis in reconstructive surgery, primary closure, or capsular flaps in case of exposure. Inflammatory markers were evaluated at admission and in postoperative days 1, 3, 5, and 7. Targeted IV antibiotics were continued after surgery.
RESULTS
We report 2 cases of successful device salvage following this protocol. The first case, a 54-year-old woman, underwent right mastectomy and prosthetic breast reconstruction; 3 years after surgery, she presented with implant infection. The second case, a 32-year-old woman, underwent periareolar augmentation mammoplasty. After 2 years, she presented with a right implant exposure (Figs. 1, 2) . Both patients were treated following our protocol 
